OptionsHouse

Options Trading News

January 16, 2013  Wed 9:42 AM CT

ONYX: SEE CHART GET CHAIN FIND STRATEGIES
Onyx Pharmaceuticals has given back much of its gains from the first days of 2013, but one trader is betting on a floor beneath the stock.

optionMONSTER's tracking systems detected the sale of 2,500 May 70 puts this morning for $2.75. The volume dwarfed the strike's open interest of just 79 contracts at the start of the session, clearly showing that this is a new position.

ONYX is down 3.13 percent to $80.82, a day after announcing that a secondary stock offering. That move led R.W. Baird to cut its price target on the name to $96 from $99 this morning, though the firm maintains an "outperform" rating on the stock.

Shares of the biopharmaceutical company began 2013 with a strong rally but hit resistance at the $86 level last week and have been falling since then. The company is scheduled to report fourth-quarter and full-year results after the close on Feb. 21.

Today's put seller is looking for the stock to close above the $70 strike price at expiration in mid-May. If ONYX is below that level, the trader will face the obligation to buy shares at an effective price of $67.25 once the credit from the put sale is included. That is near support levels going back to mid-July. (See our Education section)

Total option volume in the name is already double its full-session average for the lats month.
Share this article with your friends


Invest Like a Monster - Las Vegas: March 13-14

Premium Services

Webinar Recording

Turbo Charge Your Trading Profits

Education & Strategy

Gamma

As we continue to discuss the Greeks, we come to the first of the strike based Greeks called Gamma. Gamma is known as the second derivative, while delta is the first.

View more education articles »